about
Therapeutic Potential of Medicinal Plants and Their Constituents on Lung Inflammatory DisordersAirway Epithelial Cell Cilia and Obstructive Lung DiseaseExhaled Breath Condensate: Technical and Diagnostic AspectsNeurophenotypes in Airway Diseases. Insights from Translational Cough Studies.Endogenous Levels of Five Fatty Acid Metabolites in Exhaled Breath Condensate to Monitor Asthma by High-Performance Liquid Chromatography: Electrospray Tandem Mass SpectrometryBreath tests in respiratory and critical care medicine: from research to practice in current perspectivesCough and its importance in COPDTRPA1 agonists evoke coughing in guinea pig and human volunteersDetermining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophagesAttenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.The role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers.Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD.Biomarkers in exhaled breath condensate: a review of collection, processing and analysis.Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate.Aryl hydrocarbon receptor-dependent retention of nuclear HuR suppresses cigarette smoke-induced cyclooxygenase-2 expression independent of DNA-binding.Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammationDetection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array.Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease.Airway inflammation and hypersensitivity induced by chronic smoking.Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patientsEffects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPDDecreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression.Biomarkers in breath condensate: a promising new non-invasive technique in free radical research.Ozone modulates IL-6 secretion in human airway epithelial and smooth muscle cellsProstacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke.Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide.Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.Prostanoids in Asthma and COPD: Actions, Dysregulation, and Therapeutic Opportunities.Bronchial epithelial spheroids: an alternative culture model to investigate epithelium inflammation-mediated COPD.Pulmonary biomarkers in chronic obstructive pulmonary disease.Emerging drugs for the treatment of chronic obstructive pulmonary disease.Outcome measures for COPD treatments: a critical evaluation.Alveolar macrophages as orchestrators of COPD.Collection of exhaled breath and exhaled breath condensate in veterinary medicine. A review.Chronic obstructive pulmonary disease: clinical signs and infections.Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2.Non-invasive biomarkers and pulmonary function in smokersChronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy.
P2860
Q28067576-676FDC9C-A1A3-453A-939D-BDFC2545DF15Q28074301-C435C624-618C-48A6-99C9-D5A6AF6C028FQ28082250-3A3B7A9F-BA12-44E2-BD11-2E4933B5B68AQ30367862-D0BEB03F-9FCB-4577-A96F-055AB48445E2Q30433649-E763A66D-C3DE-4AE8-936D-5A207E4EE9FEQ30448113-1CFDC5FF-0B4B-415C-B173-C1218EAA88BFQ30488037-75CF4E2E-67CE-4C33-B43B-08708F715A24Q30491971-62F0DBF5-0B72-4D93-B00E-4DFCCD8A28B8Q33556311-2544558E-3C71-4047-88F9-FA257109551EQ33564601-E78CEE7F-46FC-4483-9486-20044FA60D86Q33764984-DC2CC01C-0357-4A30-A2EE-E5FFF97C5D6DQ34113892-51C6E69E-B0D0-4F58-B85B-BBB5F4F82800Q34274539-004B1DA6-C3A6-484C-914D-765A2462AABDQ34684120-539F8102-1D7A-4C5F-9C2F-676CBC1B53CDQ34700326-9562CBC5-BBA4-47B4-97D0-3437152F38ECQ35005262-7D4017E0-588B-4B50-AFA5-1AA7EAC9DA18Q35070135-EEE85C87-76CA-42E3-B030-0CB40B989795Q35161490-42C49449-2043-4DBC-AEC0-8E6EEEB0ABCAQ35161579-677AF8DD-1B0E-41A4-94F7-24BDCFE04C4BQ35204615-80721FCB-2BA9-4344-ABDE-06D48FDD2E02Q35536727-8760A8BE-5C81-4110-A822-6A400E02E8D0Q35537218-8F165B46-D537-4BBB-9B1D-ADDCC9C6C969Q35595232-2890464C-F2F5-422C-B468-E03E8AE1C8B2Q35644132-F4C66BAA-F1F2-49B9-8F20-89583EEF27A3Q35776527-12097A2B-0680-47D5-9605-78B5182FCD64Q35855195-1EF3D8EE-7DFB-4947-966A-47440BC46FD2Q35924777-525A269F-51B3-470C-B942-475F21602D85Q36025380-16ED82B1-A497-4C03-8AEA-B06675BD2A9FQ36112558-ECB5E960-52D4-4246-AE15-E73DCF72BB85Q36243240-F4FCB507-D130-4C11-A6B9-42F2C38D35C9Q36407068-3D17CA62-793B-4CFD-8C30-E411F6EDDA91Q36429908-956C8F52-4178-42A5-904C-EDE161451933Q36458412-4D508125-207F-4397-86DA-FAD0D832EE24Q36602287-41B586BF-F9CD-4817-ABBF-CDC6DD53D902Q36602291-4C682A42-A4B4-474D-A7C2-C94173B92E4CQ36628503-66F9F010-F085-4629-B2A0-8D9B0648C86CQ36654855-641899CD-2592-4352-A0FA-0D62B49525F6Q36796418-48D8DC62-ACBE-48D0-9238-A5D63AC70F1BQ36859381-0137F292-ADA5-4F43-B86C-273A1BE95822Q36861614-3B81CB06-B9ED-4A46-BDE4-65A1D1459B22
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Exhaled leukotrienes and prostaglandins in COPD.
@ast
Exhaled leukotrienes and prostaglandins in COPD.
@en
type
label
Exhaled leukotrienes and prostaglandins in COPD.
@ast
Exhaled leukotrienes and prostaglandins in COPD.
@en
prefLabel
Exhaled leukotrienes and prostaglandins in COPD.
@ast
Exhaled leukotrienes and prostaglandins in COPD.
@en
P2093
P2860
P356
P1433
P1476
Exhaled leukotrienes and prostaglandins in COPD
@en
P2093
G Ciabattoni
P J Barnes
S A Kharitonov
P2860
P304
P356
10.1136/THORAX.58.7.585
P407
P577
2003-07-01T00:00:00Z